Gain Therapeutics (GANX) Q4 2024 Earnings

14NovConfirmed
Q3 2023
Q2 2024
Q3 2024
Q4 2024
-0.45
-0.36
-0.26
-0.17

Details

Expected EPS
-0.20722
Actual EPS
-0.17
Surprise EPS
0.04
Surprise Percent
+17.96%

Description

Gain Therapeutics (GANX) has reported earnings of -0.17 per share for Q4 2024.

0 Comments

Share your thoughts